ArticleTranslational andrology and urology2025
Association between early age at menarche and overactive bladder risk in women: insights from NHANES and Mendelian randomization analysis.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genitourinary symptoms and sexual dysfunction in women with premature ovarian insufficiency: a cross-sectional study with age-comparable controls.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early age at menarche (AAM) has been linked to adverse metabolic trajectories that may influence bladder function, but the association between AAM and overactive bladder (OAB), and the mediating role of body mass index (BMI), remains unclear. This study aimed to examine the association of AAM with OAB risk, quantify BMI mediation, and evaluate causality using Mendelian randomization (MR). Methods: We analyzed data from 9,647 women in the National Health and Nutrition Examination Survey (NHANES, 2011-2018). OAB was defined by an Overactive Bladder Symptom Score (OABSS) ≥3. Multivariable logistic regression and restricted cubic spline (RCS) analyses evaluated the AAM-OAB relationship, adjusting for demographic, clinical, and lifestyle confounders. Mediation analysis quantified BMI's role. MR analysis, using 156 single-nucleotide polymorphisms (SNPs) from the Integrative Epidemiology Unit (IEU) Open Genome-Wide Association Study (GWAS) database, validated causality. Results: Each one-year increase in AAM was associated with a 5% reduced OAB risk [odds ratio (OR): 0.95, 95% confidence interval (CI): 0.93-0.98, P<0.001]. Compared to the earliest AAM quartile (Q1), Q2 (OR: 0.86, 95% CI: 0.77-0.97, P=0.01) and Q4 (OR: 0.81, 95% CI: 0.70-0.93, P=0.003) showed lower OAB risk. RCS analysis confirmed a linear inverse relationship (P-non-linear =0.107). BMI mediated 30.89% of the AAM-OAB association (indirect effect: -0.004, 95% CI: -0.005 to -0.004, P<2×10-16). MR analysis supported causality (OR: 0.998, 95% CI: 0.996-0.999, P=0.008), with no pleiotropy (MR-Egger intercept P=0.87). Conclusions: Early AAM increases OAB risk, partially mediated by BMI, with causal evidence from MR. Screening for early AAM and managing weight may reduce OAB risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.